Erlocip

Erlocip (Erlotinib)

Active IngredientErlotinib
Dosage FormTablet
Available Strength100mg, 150mg
Manufacturer:Cipla Limited
Packaging30 tablets in 1 bottle
Therapeutic useNon-small cell lung cancer, Pancreatic cancer
Pack Insert/LeafletYes
Production Capacity1 Million Bottle's/Month

Description